about
The microbiota and immune response during Clostridium difficile infection.Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection.In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin BIntestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections.The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Clostridium difficile-induced colitis in mice is independent of leukotrienesMechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumabNew role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strainsRole of microbiota and innate immunity in recurrent Clostridium difficile infection.Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.Clostridium difficile colitis: pathogenesis and host defenceClostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.Clostridium difficile infection in the twenty-first century.The host immune response to Clostridium difficile infectionProlonged Clostridium difficile Infection May Be Associated With Vitamin D Deficiency.Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity.Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration.Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Management of candidemia in patients with Clostridium difficile infection.Role of the leukocyte response in normal and immunocompromised host after Clostridium difficile infection.Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells.Characteristics and Immunological Roles of Surface Layer Proteins in Clostridium difficile.Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.Prolonged Mechanical Ventilation Assistance Interacts Synergistically with Carbapenem for Infection in Critically Ill Patients
P2860
Q30276756-55006CC8-8FD4-46D0-8700-644AB40FEA8EQ30300874-0FE0AE29-148A-48B2-9867-96C3695FAB19Q30414030-47C4FB7A-BC45-4AFD-A367-002037C9A9D9Q33903892-25EA6863-1EEC-47E0-A208-A04DBCA05333Q34623572-252762AB-1E25-4DEF-910A-6BAC63413FE1Q34644107-5E7EEC26-E6CE-4068-B92A-916F831D46C4Q34955629-8889E664-4261-4BFF-BCA1-CCF16B9790EFQ35098190-EDCF0AF1-BC35-4E30-A4BA-896FEE710F9CQ35201232-B3C89C98-F3B0-4B47-BE6E-B1E144A76AB1Q36018079-E8D01B92-A7EE-4503-BD62-056CFED0B4C0Q36116428-B758EC51-0ECF-417B-8A10-59B3EB710118Q36190012-60720092-ABE9-4C7B-866D-C6F0896DE91DQ36439081-22E68966-3747-4CCB-92DB-4065AD41F58CQ37289567-C49DCA69-AF37-447E-A0EA-D58F5D9639C5Q38244134-55ED2C0F-CCA2-4133-96BF-CCA804851B0DQ38333396-76FA144B-D96A-43E6-8DA5-06BD005628E7Q38737485-D3598F99-C5B5-40D3-BC82-F3C7DCD563F3Q38755888-95BE2415-9C27-4679-9983-F4F7D545EA8FQ38765888-41BF5C0C-4ADF-451E-8E68-DA49C34F92F6Q38794312-25501CBD-A5C3-48EA-BF80-3133757867C6Q38851595-073E317B-F73E-4873-A7EC-308318EF7730Q39145792-7AC6092D-386F-4836-A845-7BBC9FB514D7Q40125340-EE0F25D7-BB1D-48E5-B34F-BEDD07EFD70BQ41387456-4318B4A4-C92D-4741-8ED0-429E4AB72796Q41990887-96DD84C4-8AD2-45C6-9605-B77B530D227DQ52639383-3D37E34C-0294-4735-9BC3-EB865B8A0B97Q52699558-56C1FF3C-0AC4-4599-BD0F-F65A27B705C9Q55194285-74DF862E-6155-4440-8B35-DD94C90105DBQ58734746-BEE71051-2251-414B-8EF5-52879EA62C00
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Immune responses to Clostridium difficile infection
@ast
Immune responses to Clostridium difficile infection
@en
type
label
Immune responses to Clostridium difficile infection
@ast
Immune responses to Clostridium difficile infection
@en
prefLabel
Immune responses to Clostridium difficile infection
@ast
Immune responses to Clostridium difficile infection
@en
P2860
P1476
Immune responses to Clostridium difficile infection
@en
P2093
William A Petri
P2860
P304
P356
10.1016/J.MOLMED.2012.09.005
P50
P577
2012-10-16T00:00:00Z